{
    "ticker": "PEN",
    "name": "Penumbra, Inc.",
    "description": "Penumbra, Inc. is a global healthcare company focused on innovative medical devices for neuro and peripheral vascular conditions. Founded in 2004 and headquartered in Alameda, California, Penumbra is dedicated to creating breakthroughs in the treatment of severe and often life-threatening medical conditions. The company's flagship products include a range of catheters and thrombectomy devices that are designed to improve patient outcomes in the treatment of stroke and other vascular conditions. Penumbra\u2019s advanced technology integrates sophisticated engineering with a deep understanding of medical need, allowing for minimally invasive interventions that can significantly reduce recovery times and enhance the quality of care. The company is committed to research and development, continuously pushing the boundaries of medical technology and improving the lives of patients globally. Penumbra not only focuses on product innovation but also on educational initiatives for healthcare professionals to ensure the safe and effective use of their products. With a strong emphasis on collaboration and partnership with healthcare providers, Penumbra seeks to transform patient care through its innovative solutions.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Alameda, California, USA",
    "founded": "2004",
    "website": "https://www.penumbrainc.com",
    "ceo": "Adam Elsesser",
    "social_media": {
        "twitter": "https://twitter.com/PenumbraInc",
        "linkedin": "https://www.linkedin.com/company/penumbra-inc"
    },
    "investor_relations": "https://investors.penumbrainc.com",
    "key_executives": [
        {
            "name": "Adam Elsesser",
            "position": "CEO"
        },
        {
            "name": "Kirk D. McCarthy",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Neurovascular Devices",
            "products": [
                "Aspiration Catheters",
                "Mechanical Thrombectomy Devices"
            ]
        },
        {
            "category": "Peripheral Vascular Devices",
            "products": [
                "Embolectomy Devices",
                "Access Products"
            ]
        }
    ],
    "seo": {
        "meta_title": "Penumbra, Inc. | Innovative Medical Devices for Vascular Conditions",
        "meta_description": "Explore Penumbra, Inc., a leader in the development of innovative medical devices for neuro and peripheral vascular conditions. Discover their commitment to advancing patient care through groundbreaking technology.",
        "keywords": [
            "Penumbra",
            "Medical Devices",
            "Neurovascular",
            "Peripheral Vascular",
            "Thrombectomy",
            "Stroke Treatment"
        ]
    },
    "faq": [
        {
            "question": "What does Penumbra specialize in?",
            "answer": "Penumbra specializes in innovative medical devices for neuro and peripheral vascular conditions."
        },
        {
            "question": "Who is the CEO of Penumbra?",
            "answer": "Adam Elsesser is the CEO of Penumbra, Inc."
        },
        {
            "question": "Where is Penumbra headquartered?",
            "answer": "Penumbra is headquartered in Alameda, California, USA."
        },
        {
            "question": "What are Penumbra's main products?",
            "answer": "Penumbra's main products include aspiration catheters and mechanical thrombectomy devices for stroke treatment."
        },
        {
            "question": "When was Penumbra founded?",
            "answer": "Penumbra was founded in 2004."
        }
    ],
    "competitors": [
        "BSX",
        "SYK",
        "ABT",
        "MDT"
    ],
    "related_stocks": [
        "JNJ",
        "ISRG",
        "BAX",
        "ZBH"
    ]
}